On December 4, the domestic nine-valent HPV vaccine was officially launched at the Aerospace Center Hospital, marking that women aged 9 to 45 in Beijing have new options for more comprehensive protection and more economical vaccination in preventing cervical cancer. The introduction of this nine-valent HPV vaccine independently developed by China and the world's second nine-valent HPV vaccine has broken the long-term monopoly situation of imported vaccines.

On December 4, the domestic nine-valent HPV vaccine was officially launched at the Aerospace Center Hospital, marking that women aged 9 to 45 in Beijing have new options for more comprehensive protection and more economical vaccination in preventing cervical cancer. The introduction of this nine-valent HPV vaccine independently developed by China and the world's second nine-valent HPV vaccine has broken the long-term monopoly situation of imported vaccines.